ScinoPharm Taiwan Ltd (1789)
Taiwan Stock Exchange · Taiwan · prices in TWD · close of 20 Oct 2026
Key indicators
| Last close | TWD 19.20 |
|---|---|
| 52-week range | 16.70 – 29.10 |
| Return, 1 month / 3 months | +5.8% / −3.8% |
| Return, 1 year / 3 years | −4.7% / −29.2% |
| Trend | Below its 200-day average |
| RSI (14) | 51 |
| Volatility (1 year) | 37.1% |
| Worst drawdown (1 year) | -36.3% |
| Average daily value traded | 9.62M TWD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
ScinoPharm Taiwan is a pharmaceutical company based in Tainan that makes active pharmaceutical ingredients and advanced intermediates for drug manufacturers. It works as a contract development and manufacturing partner, producing these ingredients for generic and innovator pharmaceutical companies that use them in finished medicines. Its customers are drug companies and healthcare suppliers in markets around the world, and its work covers process development, scale-up and commercial production of chemical ingredients for prescription medicines.
ScinoPharm Taiwan Ltd trades under the code 1789 on the Taiwan Stock Exchange in Taiwan, with its price quoted in New Taiwan dollars (TWD). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
ScinoPharm Taiwan Ltd (1789) trades on the Taiwan Stock Exchange in Taiwan. It last closed at TWD 19.20 on 20 October 2026.
Its price-based Market X-Ray is 35 out of 100 (a weak price profile), ranking 862 of 1,101 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 4.7% and over the last three months it fell 3.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Taiwan Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 27 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -6.1% | ||
| From 52-week high | -32.0% | ||
| Momentum | 33 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -3.8% | ||
| 6-month return | -10.5% | ||
| 12-month return, skipping the last month | -9.9% | ||
| Stability (higher is calmer) | 45 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 37.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -36.3% | ||
| Liquidity | 37 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 9.62M TWD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −1.0% |
|---|---|
| 1 month | +5.8% |
| 3 months | −3.8% |
| 6 months | −10.5% |
| 1 year | −4.7% |
| 3 years | −29.2% |
| 5 years | – |
Signals
| 50-day / 200-day average | 18.97 / 20.45 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.49 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 6 Jul 2023 | TWD 0.3600 |
| 7 Jul 2022 | TWD 0.4800 |
| 26 Aug 2021 | TWD 0.5000 |
| 23 Jul 2020 | TWD 0.2700 |
| 25 Jul 2019 | TWD 0.4900 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Taiwan Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.